UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 15, 2019
RESTORATION ROBOTICS, INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
001-38238 |
06-1681204 |
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification Number) |
128 Baytech Drive
San Jose, California
(Address of principal executive offices, including Zip Code)
Registrant’s telephone number, including area code: (408) 883-6888
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 2.02 |
Results of Operations and Financial Condition. |
On March 15, 2019, the Company issued a press release relating to its financial results for the three months and full year ended December 31, 2018. The full text of the press release is furnished herewith as Exhibit 99.1.
The information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
|
Item 9.01 |
Financial Statements and Exhibits. |
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RESTORATION ROBOTICS, INC. |
||
|
|
|
|
||
|
Date: March 15, 2019 |
|
By: |
|
/s/ Ryan Rhodes Ryan Rhodes President, Chief Executive Officer |
|
|
Exhibit 99.1
|
Restoration Robotics® Reports Financial Results for the Fourth Quarter and Full Year 2018
Reports Fourth Quarter Revenue of $6.7 million, Up 14% Year-Over-Year
SAN JOSE, Calif., March 15, 2019 (GLOBE NEWSWIRE) – Restoration Robotics, Inc. (NASDAQ: HAIR), a global leader in robotic hair restoration, announced today financial results for the fourth quarter and full year ended December 31, 2018.
Highlights:
|
|
• |
Reported fourth quarter 2018 revenue of $6.7 million, up 14% year over year and 38% since the third quarter, primarily due to the sale of 17 ARTAS® Systems worldwide |
|
|
• |
Achieved full year 2018 revenue of $22.0 million, up 3% year-over-year |
|
|
• |
Launched ARTAS iX™ Robotic Hair Restoration System with implantation functionality in July 2018 |
|
|
• |
Completed follow-on public offering of common stock for gross proceeds of $17.3 million in August 2018 |
|
|
• |
Appointed board member and aesthetic industry commercial expert Keith Sullivan as Interim Chief Commercial Officer in November 2018 |
|
|
• |
Secured $5.0 million from the issuance of convertible promissory notes to certain members of the Board of Directors in February 2019 |
Fourth Quarter and Full Year 2018 Financial Results
Revenue in the fourth quarter of 2018 was $6.7 million, a 14% increase from $5.9 million in the fourth quarter of 2017. Revenue for 2018 was $22.0 million, a 3% increase from $21.3 million for 2017.
Gross margin in the fourth quarter of 2018 was 39% compared to 47% in the fourth quarter of 2017. Gross margin for 2018 was 43%, flat from full year 2017. The change in gross margin for the fourth quarter and year-over-year was primarily driven by the implementation of certain cost efficiencies, which were partially offset by higher initial manufacturing, warranty and other costs associated with ARTAS® iX.
Operating expenses in the fourth quarter of 2018 were $9.8 million, a 50% increase from $6.6 million in the fourth quarter of 2017. Operating expenses for 2018 were $35.4 million, an increase of 34% from $26.4 million for 2017. The increase in operating expenses in both periods was largely due to increased investments in the Company’s sales and marketing initiatives and reserves that were made for customers’ accounts receivable primarily outside of the United States.
128 Baytech Drive | San Jose, CA 95134 | T +1 408.883.6888
|
|
Exhibit 99.1
|
Net loss for the fourth quarter of 2018 was $(8.0) million or $(0.20) per share, compared with a net loss of $(1.1) million, or $(0.04) per share, for the fourth quarter of 2017. Net loss for the full year 2018 was $(28.7) million or $(0.86) per share, compared to $(17.8) million or $(2.42) per share for the full year 2017.
Total cash and cash equivalents were $16.1 million as of December 31, 2018. Cash and cash equivalents as of December 31, 2018 does not include the proceeds of $5.0 million from the Company’s issuance of Convertible Promissory Notes finalized on February 28, 2019.
About Restoration Robotics
Restoration Robotics, Inc., is a medical device company developing and commercializing the ARTAS® and ARTAS iX™ Robotic Hair Restoration System. The ARTAS Systems are the first and only physician-assisted robotic systems to dissect and assist in the harvesting of follicular units directly from the scalp, create recipient implant sites using proprietary algorithms and, in the case of the ARTAS iX System, robotically implant the hair follicles into the designated sites. The Company has unique expertise in machine vision, image guidance, visual servoing and robotics, as well as developing intuitive interfaces to manage these technologies.
Forward-Looking Statements
Statements made in this press release that are not statements of historical fact are forward-looking statements. Forward-looking statements are subject to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as “would,” “may,” “expects,” “believes,” “plans,” “intends,” “projects” and other terms with similar meaning. Investors are cautioned that the forward-looking statements in this document are based on current beliefs, assumptions and expectations, speak only as of the date of this document and involve risks and uncertainties that could cause actual results to differ materially from current expectations. Such statements are subject to certain known and unknown risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results and other future events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Material factors that could cause actual results to differ materially from current expectations include, without limitation, the following: the progress of our commercialization, marketing and manufacturing capabilities; the number of ARTAS Systems we sell; the timing or likelihood of regulatory filings and approvals for ARTAS for use in transplanting of hair; and our potential delisting from Nasdaq, including reduced trading liquidity and market price of our common stock. These factors, together with those that are described in greater detail in our Annual Report on Form 10-K for the year ended 2017 filed on March 5, 2018 and our Quarterly Report on Form 10-Q for the nine months ended September 30, 2018 filed on November 5, 2018, as well as any reports that we may file with the SEC in the future, including our Annual Report on Form 10-K for the year ended 2018 may cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by our
128 Baytech Drive | San Jose, CA 95134 | T +1 408.883.6888
|
|
Exhibit 99.1
|
forward-looking statements. We expressly disclaim any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.
Media Contact
The Ruth Group
Kirsten Thomas
kthomas@theruthgroup.com
646-536-7000
Investor Contact
The Ruth Group
Brian Johnston
bjohnston@theruthgroup.com
646-536-7000
128 Baytech Drive | San Jose, CA 95134 | T +1 408.883.6888
|
|
Exhibit 99.1
|
Consolidated Statements of Operations
(Unaudited)
(in thousands, except share and per share data)
|
|
|
Three Months Ended |
|
|
Twelve Months Ended |
|
||||||||||
|
|
|
December 31, |
|
|
December 31, |
|
||||||||||
|
|
|
2018 |
|
|
2017 |
|
|
2018 |
|
|
2017 |
|
||||
|
Revenue |
|
$ |
6,658 |
|
|
$ |
5,856 |
|
|
$ |
21,956 |
|
|
$ |
21,297 |
|
|
Cost of revenue |
|
|
4,088 |
|
|
|
3,097 |
|
|
|
12,450 |
|
|
|
12,150 |
|
|
Gross profit |
|
|
2,570 |
|
|
|
2,759 |
|
|
|
9,506 |
|
|
|
9,147 |
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
5,057 |
|
|
|
3,653 |
|
|
|
18,204 |
|
|
|
14,390 |
|
|
Research and development |
|
|
2,088 |
|
|
|
1,557 |
|
|
|
8,374 |
|
|
|
7,135 |
|
|
General and administrative |
|
|
2,674 |
|
|
|
1,355 |
|
|
|
8,834 |
|
|
|
4,904 |
|
|
Total operating expenses |
|
|
9,819 |
|
|
|
6,565 |
|
|
|
35,412 |
|
|
|
26,429 |
|
|
Loss from operations |
|
|
(7,249 |
) |
|
|
(3,806 |
) |
|
|
(25,906 |
) |
|
|
(17,282 |
) |
|
Other income (expense), net: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
(735 |
) |
|
|
(420 |
) |
|
|
(2,224 |
) |
|
|
(2,027 |
) |
|
Gain on sale of investment |
|
|
— |
|
|
|
1,851 |
|
|
|
— |
|
|
|
1,851 |
|
|
Other income (expense), net |
|
|
18 |
|
|
|
1,317 |
|
|
|
(549 |
) |
|
|
(328 |
) |
|
Total other income (expense), net |
|
|
(717 |
) |
|
|
2,748 |
|
|
|
(2,773 |
) |
|
|
(504 |
) |
|
Net loss before provision for income taxes |
|
|
(7,966 |
) |
|
|
(1,058 |
) |
|
|
(28,679 |
) |
|
|
(17,786 |
) |
|
Provision for income taxes |
|
|
15 |
|
|
|
6 |
|
|
47 |
|
|
|
56 |
|
|
|
Net loss |
|
$ |
(7,981 |
) |
|
$ |
(1,064 |
) |
|
$ |
(28,726 |
) |
|
$ |
(17,842 |
) |
|
Net loss per share, basic and diluted |
|
$ |
(0.20 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.86 |
) |
|
$ |
(2.42 |
) |
|
Weighted-average shares used in computing net loss per share, basic and diluted |
|
|
40,676,512 |
|
|
|
24,482,912 |
|
|
|
33,512,181 |
|
|
|
7,382,715 |
|
128 Baytech Drive | San Jose, CA 95134 | T +1 408.883.6888
|
|
Exhibit 99.1
|
(Unaudited)
(in thousands, except share and per share data)
|
|
|
December 31 |
|
|
December 31 |
|
||
|
|
|
2018 |
|
|
2017 |
|
||
|
ASSETS |
|
|
|
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
16,122 |
|
|
$ |
23,545 |
|
|
Accounts receivable, net of allowance |
|
|
6,569 |
|
|
|
3,864 |
|
|
Inventory |
|
|
5,522 |
|
|
|
2,761 |
|
|
Prepaid expenses and other current assets |
|
|
1,278 |
|
|
|
1,562 |
|
|
Total current assets |
|
|
29,491 |
|
|
|
31,732 |
|
|
Property and equipment, net |
|
|
1,299 |
|
|
|
1,138 |
|
|
Restricted cash |
|
|
83 |
|
|
|
100 |
|
|
Other assets |
|
|
100 |
|
|
|
— |
|
|
TOTAL ASSETS |
|
$ |
30,973 |
|
|
$ |
32,970 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
3,815 |
|
|
$ |
2,044 |
|
|
Accrued compensation |
|
|
1,771 |
|
|
|
1,630 |
|
|
Other accrued liabilities |
|
|
2,337 |
|
|
|
1,125 |
|
|
Deferred revenue |
|
|
1,407 |
|
|
|
1,517 |
|
|
Current portion of long-term debt, net |
|
|
49 |
|
|
|
7,730 |
|
|
Total current liabilities |
|
|
9,379 |
|
|
|
14,046 |
|
|
Other long-term liabilities |
|
|
594 |
|
|
|
459 |
|
|
Long-term debt, net |
|
|
19,418 |
|
|
|
5,271 |
|
|
TOTAL LIABILITIES |
|
|
29,391 |
|
|
|
19,776 |
|
|
|
|
|
|
|
|
|
|
|
|
Convertible preferred stock, $0.0001 par value; 10,000,000 shares authorized, and no shares issued and outstanding as of December 31, 2018 and December 31, 2017 |
|
— |
|
|
— |
|
||
|
STOCKHOLDERS’ EQUITY: |
|
|
|
|
|
|
|
|
|
Common stock, $0.0001 par value; 300,000,000 shares authorized as of December 31, 2018 and December 31, 2017; 40,677,012 and 28,940,282 shares issued and outstanding as of December 31, 2018 and December 31, 2017 |
|
|
4 |
|
|
|
3 |
|
|
Additional paid-in capital |
|
|
194,841 |
|
|
|
177,757 |
|
|
Accumulated other comprehensive loss |
|
|
(50 |
) |
|
|
(79 |
) |
|
Accumulated deficit |
|
|
(193,213 |
) |
|
|
(164,487 |
) |
|
TOTAL STOCKHOLDERS’ EQUITY |
|
|
1,582 |
|
|
|
13,194 |
|
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
$ |
30,973 |
|
|
$ |
32,970 |
|
128 Baytech Drive | San Jose, CA 95134 | T +1 408.883.6888